Perfetto E - Search Results

1

A Useful and Sustainable Role for N-of-1 Trials in the Healthcare Ecosystem.

Selker HP, Cohen T, D'Agostino RB, Dere WH, Ghaemi SN, Honig PK, Kaitin KI, Kaplan HC, Kravitz RL, Larholt K, McElwee NE, Oye KA, Palm ME, Perfetto E, Ramanathan C, Schmid CH, Seyfert-Margolis V, Trusheim M, Eichler HG. Selker HP, et al. Among authors: perfetto e. Clin Pharmacol Ther. 2022 Aug;112(2):224-232. doi: 10.1002/cpt.2425. Epub 2021 Oct 20. Clin Pharmacol Ther. 2022. PMID: 34551122 Free PMC article. Review.

2

Future of Patients in Healthcare Evaluation: The Patient-Informed Reference Case.

Slejko JF, Mattingly TJ 2nd, Mullins CD, Perfetto EM, dosReis S. Slejko JF, et al. Value Health. 2019 May;22(5):545-548. doi: 10.1016/j.jval.2019.02.003. Value Health. 2019. PMID: 31104732 Free article.

3

Value-based evidence across health care sectors: a push for transparent real-world studies, data, and evidence dissemination.

van den Broek RWM, Matheis RJ, Bright JL, Hartog TE, Perfetto EM. van den Broek RWM, et al. Among authors: perfetto em. Health Econ Policy Law. 2022 Oct;17(4):416-427. doi: 10.1017/S1744133122000056. Epub 2022 Apr 6. Health Econ Policy Law. 2022. PMID: 35382923

4

Selection of clinical, patient-reported, and economic end points in acute exacerbation of chronic bronchitis.

Perfetto EM, Mullins CD, Subedi P, Li-McLeod J. Perfetto EM, et al. Clin Ther. 2001 Oct;23(10):1747-72. doi: 10.1016/s0149-2918(01)80142-9. Clin Ther. 2001. PMID: 11726009 Review.

5

Defining Patient Engagement in Research: Results of a Systematic Review and Analysis: Report of the ISPOR Patient-Centered Special Interest Group.

Harrington RL, Hanna ML, Oehrlein EM, Camp R, Wheeler R, Cooblall C, Tesoro T, Scott AM, von Gizycki R, Nguyen F, Hareendran A, Patrick DL, Perfetto EM. Harrington RL, et al. Value Health. 2020 Jun;23(6):677-688. doi: 10.1016/j.jval.2020.01.019. Epub 2020 May 23. Value Health. 2020. PMID: 32540224 Free article.

6

What are outcomes?

Mullins CD, Baldwin R, Perfetto EM. Mullins CD, et al. Among authors: perfetto em. J Am Pharm Assoc (Wash). 1996 Jan;NS36(1):39-49. doi: 10.1016/s1086-5802(16)30005-5. J Am Pharm Assoc (Wash). 1996. PMID: 8835440 Review.

7

What Are the Incentives for Medicare Prescription Drug Plans to Consider Long-Term Outcomes and Cost?

Hung A, Perfetto EM. Hung A, et al. J Manag Care Spec Pharm. 2016 Jul;22(7):773-8. doi: 10.18553/jmcp.2016.22.7.773. J Manag Care Spec Pharm. 2016. PMID: 27348277 Free PMC article.

8

ISPOR's Initiative on US Value Assessment Frameworks: A Missed Opportunity for ISPOR and Patients.

Perfetto EM. Perfetto EM. Value Health. 2018 Feb;21(2):169-170. doi: 10.1016/j.jval.2017.12.002. Value Health. 2018. PMID: 29477396 Free article. No abstract available.

9

Patient-Reported Outcome Measures in the Food and Drug Administration Pilot Compendium: Meeting Today's Standards for Patient Engagement in Development?

Oehrlein EM, Perfetto EM, Love TR, Chung Y, Ghafoori P. Oehrlein EM, et al. Value Health. 2018 Aug;21(8):967-972. doi: 10.1016/j.jval.2018.01.004. Epub 2018 Mar 9. Value Health. 2018. PMID: 30098675 Free article.

10

What Matters Most for Treatment Decisions in Hepatitis C: Effectiveness, Costs, and Altruism.

Mattingly TJ 2nd, Slejko JF, Perfetto EM, Kottilil S, Mullins CD. Mattingly TJ 2nd, et al. Patient. 2019 Dec;12(6):631-638. doi: 10.1007/s40271-019-00378-7. Patient. 2019. PMID: 31347011

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

99 results

Search Page

Filters